Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.

<h4>Introduction</h4>Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adheren...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seth Zissette, Elizabeth E Tolley, Andres Martinez, Homaira Hanif, Katherine Gill, Nelly Mugo, Laura Myers, Ednar Casmir, Menna Duyver, Kenneth Ngure, Gustavo F Doncel
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b2d902d873f147d580fad67ae332ba2f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b2d902d873f147d580fad67ae332ba2f
record_format dspace
spelling oai:doaj.org-article:b2d902d873f147d580fad67ae332ba2f2021-11-25T06:23:45ZAdaptation and validation of simple tools to screen and monitor for oral PrEP adherence.1932-620310.1371/journal.pone.0251823https://doaj.org/article/b2d902d873f147d580fad67ae332ba2f2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0251823https://doaj.org/toc/1932-6203<h4>Introduction</h4>Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intravaginal ring adherence within the context of HIV prevention clinical trials. This study aimed to further validate the screening tool and to adapt and provide initial psychometric validation for an oral pill monitoring tool.<h4>Materials and methods</h4>We administered a cross-sectional survey between June and October 2018 at a trial site located near Cape Town, South Africa, and another in Thika, Kenya, with 193 women who had experience using daily oral pills. We fit confirmatory factor analysis models on the screening tool items to assess our previously-hypothesized subscale structure. We conducted an exploratory factor analysis of oral PrEP monitoring items to determine the underlying subscale structure. We then assessed the construct validity of each tool by comparing subscales against each other within the current sample and against our original sample, from a study conducted in four sites in South Africa, including Cape Town.<h4>Results</h4>The screening tool structure showed moderate evidence of construct validity. As a whole, the tool performed in a similar way to the original sample. The monitoring tool items, which were revised to assess perceptions about and experiences using daily oral PrEP, factored into five subscales that showed moderate to good reliability. Four of the five subscales had a similar structure overall to the vaginal ring monitoring tool from which they were adapted.<h4>Conclusions</h4>Accurate measurement of HIV-prevention product adherence is of critical importance to the assessment of product efficacy and safety in clinical trials, and the support of safe and effective product use in non-trial settings. In this study, we provide further validation for these measures, demonstrating the screening tool's utility in additional populations and adapting the monitoring tool's utility for different HIV-prevention products.Seth ZissetteElizabeth E TolleyAndres MartinezHomaira HanifKatherine GillNelly MugoLaura MyersEdnar CasmirMenna DuyverKenneth NgureGustavo F DoncelPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 5, p e0251823 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Seth Zissette
Elizabeth E Tolley
Andres Martinez
Homaira Hanif
Katherine Gill
Nelly Mugo
Laura Myers
Ednar Casmir
Menna Duyver
Kenneth Ngure
Gustavo F Doncel
Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
description <h4>Introduction</h4>Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intravaginal ring adherence within the context of HIV prevention clinical trials. This study aimed to further validate the screening tool and to adapt and provide initial psychometric validation for an oral pill monitoring tool.<h4>Materials and methods</h4>We administered a cross-sectional survey between June and October 2018 at a trial site located near Cape Town, South Africa, and another in Thika, Kenya, with 193 women who had experience using daily oral pills. We fit confirmatory factor analysis models on the screening tool items to assess our previously-hypothesized subscale structure. We conducted an exploratory factor analysis of oral PrEP monitoring items to determine the underlying subscale structure. We then assessed the construct validity of each tool by comparing subscales against each other within the current sample and against our original sample, from a study conducted in four sites in South Africa, including Cape Town.<h4>Results</h4>The screening tool structure showed moderate evidence of construct validity. As a whole, the tool performed in a similar way to the original sample. The monitoring tool items, which were revised to assess perceptions about and experiences using daily oral PrEP, factored into five subscales that showed moderate to good reliability. Four of the five subscales had a similar structure overall to the vaginal ring monitoring tool from which they were adapted.<h4>Conclusions</h4>Accurate measurement of HIV-prevention product adherence is of critical importance to the assessment of product efficacy and safety in clinical trials, and the support of safe and effective product use in non-trial settings. In this study, we provide further validation for these measures, demonstrating the screening tool's utility in additional populations and adapting the monitoring tool's utility for different HIV-prevention products.
format article
author Seth Zissette
Elizabeth E Tolley
Andres Martinez
Homaira Hanif
Katherine Gill
Nelly Mugo
Laura Myers
Ednar Casmir
Menna Duyver
Kenneth Ngure
Gustavo F Doncel
author_facet Seth Zissette
Elizabeth E Tolley
Andres Martinez
Homaira Hanif
Katherine Gill
Nelly Mugo
Laura Myers
Ednar Casmir
Menna Duyver
Kenneth Ngure
Gustavo F Doncel
author_sort Seth Zissette
title Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
title_short Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
title_full Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
title_fullStr Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
title_full_unstemmed Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence.
title_sort adaptation and validation of simple tools to screen and monitor for oral prep adherence.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/b2d902d873f147d580fad67ae332ba2f
work_keys_str_mv AT sethzissette adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT elizabethetolley adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT andresmartinez adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT homairahanif adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT katherinegill adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT nellymugo adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT lauramyers adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT ednarcasmir adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT mennaduyver adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT kennethngure adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
AT gustavofdoncel adaptationandvalidationofsimpletoolstoscreenandmonitorfororalprepadherence
_version_ 1718413765455642624